Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tennis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the Neurological Sciences|May 1, 1995
Environment-driven responses in progressive supranuclear palsyJ Ghika, M Tennis, J Growdon, et al.
Neurology|July 1, 1991
Idazoxan treatment in progressive supranuclear palsyJ Ghika, M Tennis, E Hoffman, et al.
Annals of Neurology|December 16, 2000
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's diseaseR M Nitsch, M Deng, M Tennis, et al.
Archives of Neurology|July 1, 1997
Pupil dilation to tropicamide is not specific for Alzheimer diseaseJ H Growdon, K Graefe, M Tennis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2009
Pathological confirmation of primary lung cancer following breast cancerM Tennis, B Singh, A Hjerpe, et al.
Neurology|November 9, 2005
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative diseaseM C Irizarry, M E Gurol, S Raju, et al.
Annals of Neurology|April 1, 1995
Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotypeR M Nitsch, G W Rebeck, M Deng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study GroupJ H Carter, B J Stewart, P G Archbold, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the Neurological Sciences|May 1, 1995
Environment-driven responses in progressive supranuclear palsyJ Ghika, M Tennis, J Growdon, et al.
Neurology|July 1, 1991
Idazoxan treatment in progressive supranuclear palsyJ Ghika, M Tennis, E Hoffman, et al.
Annals of Neurology|December 16, 2000
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's diseaseR M Nitsch, M Deng, M Tennis, et al.
Archives of Neurology|July 1, 1997
Pupil dilation to tropicamide is not specific for Alzheimer diseaseJ H Growdon, K Graefe, M Tennis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2009
Pathological confirmation of primary lung cancer following breast cancerM Tennis, B Singh, A Hjerpe, et al.
Neurology|November 9, 2005
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative diseaseM C Irizarry, M E Gurol, S Raju, et al.
Annals of Neurology|April 1, 1995
Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotypeR M Nitsch, G W Rebeck, M Deng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study GroupJ H Carter, B J Stewart, P G Archbold, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 1